Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase
The Board of Directors of Zoetis has announced a dividend of $0.375 per share for Q1 2023, marking a 15% increase from 2022. This dividend will be paid on March 1, 2023, to shareholders on record as of January 20, 2023. Executive VP and CFO Wetteny Joseph highlighted the company's robust product portfolio and global presence as key factors for generating increased cash flow for future investments and returning capital to shareholders.
- 15% increase in quarterly dividend from 2022 to $0.375 per share, reflecting strong performance.
- Zoetis reported a revenue of $7.8 billion in 2021, showcasing solid financial health.
- None.
“Zoetis has continued to perform well this year thanks to our diverse, durable product portfolio and global scale,” said Wetteny Joseph, Executive Vice President and Chief Financial Officer at Zoetis. “We are well-positioned to generate increased cash for future investment opportunities, and I am pleased to announce that we are increasing our dividend by
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of
DISCLOSURE NOTICES
Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended
ZTS-COR
ZTS-IR
ZTS-FIN
View source version on businesswire.com: https://www.businesswire.com/news/home/20221208005810/en/
Media Contacts:
1-973-443-2742 (o)
william.price@zoetis.com
1-973-443-2777 (o)
kristen.seely@zoetis.com
Investor Contact:
1-973-822-7141 (o)
steve.frank@zoetis.com
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Source:
FAQ
What is the dividend amount for Zoetis in Q1 2023?
When will Zoetis pay its dividend?
What is the record date for Zoetis' dividend payment?
How much has Zoetis increased its dividend in 2023?